They found that NK cell (CD3-CD7+ GZMB+) subsets were depleted in active TB patients, and this cell population recovered in cured TB patients, suggesting that this NK subset could be a marker to identify active TB patients and monitor treatment response [74]. The gene discussed is CD7; the disease is tuberculosis.